Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.48 is 59% below its 5-year average of -0.93, near the low end of its 5-year range (-1.49–-0.36).
7.64% below its 12-month average of -1.38.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.22.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 39 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T18:48:27.803Z. Historical observations retain their original dates. Historical series through 2021-03-16.
EARNINGS PER SHARE (EPS)
-1.48
EARNINGS PER SHARE (EPS) AVG TTM
-1.38
EARNINGS PER SHARE (EPS) AVG 3Y
-1.16
EARNINGS PER SHARE (EPS) AVG 5Y
-0.93
EARNINGS PER SHARE (EPS) AVG 10Y
0.65
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-7.64%
CURRENT VS 3Y AVG
-27.59%
CURRENT VS 5Y AVG
-59.14%
CURRENT VS 10Y AVG
-326.11%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
XBiotech Inc.
Market Cap
$66.16M
Earnings Per Share (EPS)
-1.48
TTM Avg
-1.38
3Y Avg
-1.16
5Y Avg
-0.93
Market Cap
$66.56M
Earnings Per Share (EPS)
-0.33
TTM Avg
-1.03
3Y Avg
-28.69
5Y Avg
-510.63
Market Cap
$67.01M
Earnings Per Share (EPS)
-5.01
TTM Avg
-7.16
3Y Avg
-89.38
5Y Avg
-71.00
Market Cap
$64.71M
Earnings Per Share (EPS)
-55.66
TTM Avg
-39.81
3Y Avg
-97.72
5Y Avg
-154.19
Market Cap
$68.08M
Earnings Per Share (EPS)
-0.08
TTM Avg
0.13
3Y Avg
-0.17
5Y Avg
-0.10
Market Cap
$63.97M
Earnings Per Share (EPS)
-0.32
TTM Avg
-0.34
3Y Avg
-0.43
5Y Avg
-0.40
Market Cap
$68.40M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.27
3Y Avg
-0.33
5Y Avg
-0.45
Market Cap
$68.60M
Earnings Per Share (EPS)
2.68
TTM Avg
-1.38
3Y Avg
-6.44
5Y Avg
-7.90
Market Cap
$63.58M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.02
3Y Avg
-0.02
5Y Avg
-0.01
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| XBiotech Inc. (XBIT) | $66.16M | -1.48 | -1.38 | -1.16 | -0.93 |
| iBio, Inc. (IBIO)vs › | $66.56M | -0.33 | -1.03 | -28.69 | -510.63 |
| Cingulate Inc. (CING)vs › | $67.01M | -5.01 | -7.16 | -89.38 | -71.00 |
| Gossamer Bio, Inc. (GOSS)vs › | $64.71M | -55.66 | -39.81 | -97.72 | -154.19 |
| Champions Oncology, Inc. (CSBR)vs › | $68.08M | -0.08 | 0.13 | -0.17 | -0.10 |
| RenovoRx, Inc. (RNXT)vs › | $63.97M | -0.32 | -0.34 | -0.43 | -0.40 |
| Tiziana Life Sciences Ltd (TLSA)vs › | $68.40M | N/A | -0.27 | -0.33 | -0.45 |
| Fortress Biotech, Inc. (FBIO)vs › | $68.60M | 2.68 | -1.38 | -6.44 | -7.90 |
| Alps Group Inc (ALPS)vs › | $63.58M | N/A | -0.02 | -0.02 | -0.01 |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.47M | -1.49 | -2.95 | -2.90 | -2.58 |
Trailing EPS (TTM)
$-1.48
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.49 |
| 2024-12-31 | -1.26 |
| 2023-12-31 | -0.81 |
| 2022-12-31 | -1.08 |
| 2021-12-31 | -0.58 |
| 2020-12-31 | -0.36 |
| 2019-12-31 | 17.17 |
| 2018-12-31 | -0.59 |
| 2017-12-31 | -0.95 |
| 2016-12-31 | -1.63 |
| 2015-12-31 | -1.22 |
| 2014-12-31 | -0.68 |
| 2013-12-31 | -0.31 |
| 2012-12-31 | -0.48 |
